Cedar Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11
Closed -$2K 193
2018
Q3
$2K Hold
11
﹤0.01% 161
2018
Q2
$2K Hold
11
﹤0.01% 199
2018
Q1
$2K Buy
+11
New +$1.84K ﹤0.01% 131
2017
Q4
Sell
-3
Closed -$1K 155
2017
Q3
$1K Hold
3
﹤0.01% 137
2017
Q2
$1K Sell
3
-50
-94% -$11.7K ﹤0.01% 140
2017
Q1
$13K Buy
+53
New +$12.3K 0.01% 102

Other funds holding AGN

Cedar Wealth Management's AGN Position: Q4 2018 in Review

Cedar Wealth Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 11 shares — an estimated $2K sold.

Cedar Wealth Management first reported a position in AGN in Q1 2017 and held it in 6 quarters. The position peaked at $13K in Q1 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Cedar Wealth Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Cedar Wealth Management sold 11 Allergan plc shares in Q4 2018, an estimated $2K.
  • Cedar Wealth Management first reported a position in Allergan plc in Q1 2017 and held it in 6 quarters.
  • Cedar Wealth Management's Allergan plc position peaked at $13K in Q1 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Cedar Wealth Management's 13F filing for Q4 2018, filed 23 Jan 2019.